T-Mobile Settlement Highlights the Importance of Precise Wording in Patent Dispute Resolutions

The recent settlement between T-Mobile and Kaifi LLC underscores the nuances and potential pitfalls associated with the wording of settlement agreements, especially concerning ex parte reexaminations (EPRs). The case revolves around T-Mobile’s strategic use of a contingency payment to finalize litigation, shedding light on the challenges faced by alleged infringers when contesting patents through the…

Read More

Patent Rulings Reinforce Challenges for Software Claims Under Supreme Court’s Alice Standard

In a recent ruling, a patent-holding entity has been mandated to pay approximately $821,000 in attorney fees and costs to eHarmony and The Meet Group. This financial obligation follows unsuccessful patent infringement lawsuits, which were challenged under the U.S. Supreme Court’s Alice Corp. v. CLS Bank International decision. The Alice test, which determines the patent…

Read More

Federal Circuit Court Sides with Amazon in Pivotal Patent Infringement Case, Reflecting Trends in Tech Patent Law

In a notable decision, a divided panel of the U.S. Court of Appeals for the Federal Circuit affirmed a lower court’s ruling favoring Amazon, absolving the tech giant from claims of patent infringement against AlterWAN Inc. The case centered around a network patent, the validity and interpretation of which have been hotly contested. The majority…

Read More

Federal Circuit Upholds Ruling: Globus Medical Cleared of Patent Infringement in Spinal Surgery Tool Case

The Federal Circuit recently affirmed a Pennsylvania federal judge’s ruling, confirming that Globus Medical Inc. did not infringe on the spinal surgery tool patents held by Moskowitz Family LLC. The decision underscored the significance of patent language, specifically how the opening statements, or preambles, can narrow the scope of patent claims. This legal interpretation was…

Read More

Norton Rose Fulbright Expands Dallas IP Litigation Team with Strategic Partner Hire from Holland & Knight

Norton Rose Fulbright has taken strategic steps to strengthen its intellectual property litigation team in Dallas by bringing on a partner from Holland & Knight LLP. The new addition is expected to bolster the firm’s capability in handling complex IP disputes, a sector experiencing heightened demand among clients seeking robust defense strategies. The lateral move…

Read More

Texas Judge Allows Cellspin’s Patent Lawsuit Against Fossil to Proceed, Differing from California Rulings

In a recent legal development, a Texas federal magistrate judge recommended that Cellspin Soft Inc.’s patent lawsuit against Fossil Stores I Inc. should not be dismissed. The case revolves around technology enabling the automatic publication of social media content, a legal battle that echoes previous proceedings in California where the allegations were dismissed. The Texas…

Read More

Patent Policies Stifle Biosimilar Development, Risking Cost Savings in Pharma Industry

A recent report by the Association for Accessible Medicines highlights a significant gap in the development of biosimilar drugs, noting that 90% of biologic products losing patent exclusivity by 2034 lack corresponding biosimilar development. This oversight threatens potential cost savings and innovation in the pharmaceutical industry, as it underscores the enduring impact of current patent…

Read More

USPTO Approves All 10 PTAB Reviews Amid Heightened Pharmaceutical Patent Scrutiny

In a move that underscores the increasing activity within the pharmaceutical intellectual property space, U.S. Patent and Trademark Office Director John Squires has instituted ten new Patent Trial and Appeal Board (PTAB) reviews. Notably, none of the 10 petitions were rejected, highlighting the critical scrutiny and evolving dynamics within patent litigation and review processes. These…

Read More

Navigating Intellectual Property Challenges in the Expanding Cannabis and Psychedelics Sectors

The booming cannabis and psychedelics industries are attracting widespread attention, presenting complex intellectual property hurdles. Over the past five months, activity within these sectors has surged, fueled by both government initiatives and commercial expansion. This rapid growth has brought renewed attention to patent strategies and the protection of innovative developments. Companies operating in cannabis and…

Read More

Declaratory Judgments Surge as Corporations Navigate Evolving Patent Challenges

As patent infringement threats continue to loom over corporations, the strategic use of declaratory judgment actions is experiencing a renewed interest. This trend is influenced by recent developments in patent law, including the evolving Patent Trial and Appeal Board (PTAB) practices and proactive measures by major platforms like Amazon. Traditionally, companies accused of patent infringement…

Read More

Delaware Court Upholds $1.6 Million Patent Infringement Verdict Against Kurin in Medical Device Dispute

In a recent development from the Delaware federal court, a judge has declined to overturn a jury verdict ordering medical device company Kurin to pay $1.6 million to Magnolia Medical Technologies. This decision comes following accusations that Kurin infringed on three patents related to blood culture collection products. The court dismissed Kurin’s request for a…

Read More

Genius Sports and Panda Interactive Settle Patent Dispute, Paving the Way for Innovation in Live Sports Betting

Genius Sports Ltd. and Panda Interactive have reached a settlement in their patent dispute concerning technology critical to the rapidly evolving sports betting industry. This agreement was confirmed through a notice filed in the Texas federal court, effectively putting an end to a contentious legal battle just before trial proceedings were set to begin. The…

Read More

Federal Circuit Scrutiny Casts Doubt on Netlist’s $445 Million Legal Win Against Micron

A $445 million verdict awarded to Netlist Inc. against Micron Technology Inc. is under intense scrutiny as the Federal Circuit examines potential pitfalls in the Patent Trial and Appeal Board’s (PTAB) prior invalidation of claims related to two critical computer memory patents. During a recent hearing, a Federal Circuit panel critically evaluated Netlist’s assertions that…

Read More

Delaware Federal Ruling Upholds Steuben Foods’ Bottle Sterilization Patents: Implications for Patent Litigation

Bottler Shibuya Hoppmann and dairy company HP Hood recently faced a legal setback when a Delaware federal judge declined their request for a new trial concerning the validity of Steuben Foods’ bottle sterilization patents. This decision followed the Federal Circuit’s partial revival of a $38 million infringement verdict against these companies. The judge’s ruling underscores…

Read More

Complex Legal Clash: Eli Lilly Pursues Unfair Competition Claims Over Compounded Medications

In a recent legal development, a California federal judge delivered a nuanced decision in a case involving pharmaceutical giant Eli Lilly. The company faced legal challenges over alleged unfair competition practices related to compounded versions of its diabetes and weight loss medications. The court dismissed Eli Lilly’s claims that a physician group and pharmacy falsely…

Read More

University of Virginia Law Professor Appointed General Counsel of USPTO, Bringing Academic Expertise to U.S. Intellectual Property Leadership

A professor from the University of Virginia School of Law has announced his intent to assume the role of General Counsel at the United States Patent and Trademark Office (USPTO). With over 15 years of experience teaching tort, administrative, patent, and international intellectual property law, his move is poised to bring a wealth of academic…

Read More

New Jersey Court Ruling Halts Sandoz’s Generic Nasal Spray over Janssen Patent Infringement

A New Jersey federal judge recently determined that Sandoz’s plans to produce a generic version of a nasal spray patented by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, would lead to patent infringement. This ruling underscores the ongoing complexities in the pharmaceutical industry where generic manufacturers frequently navigate the delicate landscape of patent boundaries….

Read More